In this issue:
Methotrexate in psoriasis patients with and without PsA
Clinical trials vs real-world populations in psoriasis
Genital psoriasis in patients consulting for psoriasis
Mirikizumab for moderate-to-severe plaque psoriasis
Treatment-resistant areas in plaque psoriasis patients on biologics
Herpes zoster in patients on systemic therapy
French guidelines for moderate-tosevere psoriasis in adults
Biological treatments for paediatric psoriasis
Systemic treatments in PsA
Sustainability and switching of biologics in psoriasis and PsA
Please login below to download this issue (PDF)